Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Personal financial planning is vital for achieving your financial goals. Learn about its importance and the process to get started.
28,655 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
A cash-flow driven income approach delivering roughly a 4.4% forward yield is gaining traction as market swings persi...
Iran tensions could ripple through travel, housing and markets beyond fuel costs. Analysts warn that higher prices ar...
Tokenized equities on-chain may alter how investors diversify. As banks test cross-rail settlement, the case for broa...
Private AI valuations are climbing into the hundreds of billions, eclipsing Walmart's public market value and prompti...
A Nasdaq-listed firm disclosed it liquidated its entire Bitcoin position, raising questions about the future of crypt...
Long-running dividend growers are showing resilience as 2026 markets churn. AWR and NFG lead a small group with 50+ y...
As the next market cycle approaches, traders are weighing XRP against Hyperliquid, weighing price action, liquidity, ...
Google's Gemini AI offers a bold Solana forecast for late 2026. The model sees a possible move up to $150-$200 if Fir...
Oil edges toward a $100 threshold as geopolitical tensions intensify. Four key energy names—Exxon, Chevron, ConocoPhi...
Microsoft and Apple are rolling out platform-native features at Build and WWDC that could squeeze rival apps. Investo...
As XRP trades near $1 in mid-2026, investors weigh the odds of a $100 price within five years as Ripple scales its pa...